Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Bosutinib (CAS 380843-75-4) stands out in the landscape of targeted cancer therapies due to its potent dual inhibition of Abl and Src kinases. This unique characteristic provides a significant advantage in treating various malignancies, particularly those driven by aberrant kinase activity. Understanding the Bosutinib mechanism of action is crucial for appreciating its role as a key pharmaceutical chemical in modern medicine.
The efficacy of Bosutinib stems from its ability to bind to and inhibit the enzymatic activity of both Abl and Src kinases. Abl kinase, often dysregulated in Chronic Myeloid Leukemia (CML) due to the BCR-ABL fusion protein, is a primary target. Simultaneously, Src kinases play critical roles in cell proliferation, survival, invasion, and angiogenesis, making them attractive targets in a broader range of cancers, including solid tumors. By inhibiting both, Bosutinib can disrupt multiple signaling pathways essential for cancer cell growth and progression.
The antiproliferative activity of Bosutinib has been extensively studied. In preclinical models, it demonstrates significant efficacy in inhibiting the growth of CML cells and cancer cells derived from solid tumors. This direct impact on cell proliferation, coupled with its potential to induce apoptosis (programmed cell death), makes it a valuable agent for drug development. The ability to buy Bosutinib and study its effects in controlled laboratory settings is vital for advancing our understanding of targeted cancer treatments. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supplying high-purity Bosutinib to facilitate this essential research.
The ongoing research and development of Bosutinib underscore its importance as a sophisticated pharmaceutical chemical. Its dual inhibition strategy and proven antiproliferative effects position it as a powerful tool in the fight against cancer. As researchers continue to explore its full therapeutic potential, the demand for reliable suppliers of Bosutinib remains high, supporting the advancement of new cancer therapies.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
